WHO ICTRP trial
Establishing a new strategy for individualized layered diagnosis and treatment…
ChiCTR2500103712 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500103712 |
|---|---|
| Public title | Establishing a new strategy for individualized layered diagnosis and treatment of type B interstitial hematoma - Thoracic endovascular Repair for patients with Unstable acute Stanford Type B intramural hemaToma (TRUST) |
| Scientific title | Establishing a new strategy for individualized layered diagnosis and treatment of type B interstitial hematoma - Thoracic endovascular Repair for patients with Unstable acute Stanford Type B intramural hemaToma (TRUST) |
| Primary sponsor | Zhongshan Hospital, Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Aortic intramural hematoma |
| Interventions | TEVAR and the best pharmacotherapy group:TEVAR in combination with optimal medical therapy;Best pharmacological treatment group:Optimal medical treatment |
| Registration date | Jun 4, 2025 |
| Target size | TEVAR and the best pharmacotherapy group:168;Best pharmacological treatment… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: